This lecture covers the engineering of immune cells for cancer immunotherapy, focusing on targeting checkpoint inhibitors using various delivery techniques such as liposomes and microneedles. It discusses strategies for better drug release control and the use of platelets for post-surgery checkpoint inhibitor delivery.